Brazilian Commission: Dan Henderson's TRT likely to be approved, non-committal on NSAC's ban

The fallout from the NSAC's decision to ban TRT continues. MMA Fighting's Guilherme Cruz reached out to the Brazilian MMA commission for comment on Dan Henderson's request for a therapeutic use exemption and their response to Nevada's outright ban:

Scheduled to meet Mauricio Rua at a UFC Fight Night card in Natal, Brazil, on March 23, "Hendo" applied for a TRT exemption for his fight in Brazil, and it will likely be approved by Brazilian MMA Athletic Commission (CABMMA).

"We have (NSAC) as a mirror, but the commissions are not bounded," CABMMA's medical director Dr. Marcio Tannure told MMAFighting.com on Thursday. "A decision made there doesn't mean that we'll agree here, or the opposite, but it starts a debate about it.

"We already debate this subject for a long time here in Brazil. Is a controversial subject, but it's on the rule. We may change our dealing or not. We haven't made a decision about it yet."

For now, CABMMA will continue to grant TRT exemptions if they think it's needed.

"It may change in the future like in Nevada," Dr. Tannure said. "Will it change? I don't know. It depends on what we think is more correct inside the sport."When asked about Chael Sonnen, another open user of TRT who's currently scheduled for a bout in Brazil in May, Dr. Tannure stated that Sonnen had yet to apply for a TUE.

In general, CABMMA was non-committal on the prospect of granting more exemptions for TRT moving forward, but it certainly sounds as if they plan on giving the issue substantial time for debate. The NSAC's decision has massive implications for every sanctioning body around the world, and Dana White's response puts additional pressure on the UFC's partner commissions to follow suit.

Stay tuned to Bloody Elbow, as we'll continue to bring you the latest on this story as it develops.

Luke Thomas from MMA Fighting discussed the big ESPN "Outside the Lines" story regarding TRT use in MMS on his Chat Wrap show earlier this week: